STERIS plc (STE)
USD 212.76
(0.07%)
USD 212.76
(0.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 3.17 Billion USD | 13.02% |
| 2023 | 2.81 Billion USD | 1.22% |
| 2022 | 2.77 Billion USD | 94.16% |
| 2021 | 1.43 Billion USD | 72.1% |
| 2020 | 830.94 Million USD | -13.68% |
| 2019 | 962.59 Million USD | -13.63% |
| 2018 | 1.11 Billion USD | -6.77% |
| 2017 | 1.19 Billion USD | -9.36% |
| 2016 | 1.31 Billion USD | 189.52% |
| 2015 | 455.56 Million USD | 33.72% |
| 2014 | 340.67 Million USD | -2.74% |
| 2013 | 350.28 Million USD | 491.9% |
| 2012 | 59.17 Million USD | 248.44% |
| 2011 | 16.98 Million USD | 441.66% |
| 2010 | -4.97 Million USD | -108.91% |
| 2009 | 55.82 Million USD | -56.43% |
| 2008 | 128.11 Million USD | 159.96% |
| 2007 | 49.28 Million USD | 13.28% |
| 2006 | 43.5 Million USD | -47.58% |
| 2005 | 82.98 Million USD | 153.53% |
| 2004 | 32.73 Million USD | -8.37% |
| 2003 | 35.72 Million USD | -65.81% |
| 2002 | 104.46 Million USD | -42.72% |
| 2001 | 182.37 Million USD | -22.41% |
| 2000 | 235.04 Million USD | 17.52% |
| 1999 | 200 Million USD | 45.03% |
| 1998 | 137.9 Million USD | 801.35% |
| 1997 | 15.3 Million USD | 7750.0% |
| 1996 | -200 Thousand USD | 87.5% |
| 1995 | -1.6 Million USD | 40.74% |
| 1994 | -2.7 Million USD | 86.43% |
| 1993 | -19.9 Million USD | -1890.0% |
| 1992 | -1 Million USD | -350.0% |
| 1991 | 400 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 3.31 Billion USD | 5.11% |
| 2024 Q1 | 2.65 Billion USD | -5.65% |
| 2024 Q2 | 3.15 Billion USD | 18.89% |
| 2024 Q4 | 3.17 Billion USD | -4.14% |
| 2024 FY | 3.17 Billion USD | 13.02% |
| 2023 Q3 | 2.83 Billion USD | -3.63% |
| 2023 FY | 2.81 Billion USD | 1.22% |
| 2023 Q4 | 2.81 Billion USD | -0.95% |
| 2023 Q2 | 2.94 Billion USD | 8.37% |
| 2023 Q1 | 2.71 Billion USD | -2.15% |
| 2022 Q4 | 2.77 Billion USD | -1.41% |
| 2022 Q2 | 3.03 Billion USD | -8.04% |
| 2022 Q1 | 3.3 Billion USD | 131.02% |
| 2022 FY | 2.77 Billion USD | 94.16% |
| 2022 Q3 | 2.81 Billion USD | -7.3% |
| 2021 FY | 1.43 Billion USD | 72.1% |
| 2021 Q3 | 1.46 Billion USD | 106.16% |
| 2021 Q4 | 1.43 Billion USD | -2.1% |
| 2021 Q1 | 766.52 Million USD | -7.75% |
| 2021 Q2 | 708.52 Million USD | -7.57% |
| 2020 Q3 | 1.06 Billion USD | 10.33% |
| 2020 Q2 | 961.65 Million USD | -1.06% |
| 2020 Q1 | 971.93 Million USD | 0.97% |
| 2020 Q4 | 830.94 Million USD | -21.68% |
| 2020 FY | 830.94 Million USD | -13.68% |
| 2019 Q1 | 1.1 Billion USD | -1.16% |
| 2019 Q4 | 962.59 Million USD | -5.76% |
| 2019 FY | 962.59 Million USD | -13.63% |
| 2019 Q2 | 1.05 Billion USD | -3.97% |
| 2019 Q3 | 1.02 Billion USD | -3.44% |
| 2018 Q1 | 1.2 Billion USD | 0.52% |
| 2018 Q3 | 1.13 Billion USD | -1.17% |
| 2018 Q4 | 1.11 Billion USD | -1.91% |
| 2018 FY | 1.11 Billion USD | -6.77% |
| 2018 Q2 | 1.14 Billion USD | -4.32% |
| 2017 Q1 | 1.3 Billion USD | -0.72% |
| 2017 Q3 | 1.24 Billion USD | -0.61% |
| 2017 Q4 | 1.19 Billion USD | -3.76% |
| 2017 FY | 1.19 Billion USD | -9.36% |
| 2017 Q2 | 1.24 Billion USD | -4.55% |
| 2016 Q2 | 667.63 Million USD | 36.26% |
| 2016 Q1 | 489.97 Million USD | 7.55% |
| 2016 Q3 | 1.4 Billion USD | 110.91% |
| 2016 Q4 | 1.31 Billion USD | -6.33% |
| 2016 FY | 1.31 Billion USD | 189.52% |
| 2015 Q2 | 472.53 Million USD | -5.64% |
| 2015 FY | 455.56 Million USD | 33.72% |
| 2015 Q1 | 500.8 Million USD | 47.0% |
| 2015 Q4 | 455.56 Million USD | -2.28% |
| 2015 Q3 | 466.16 Million USD | -1.35% |
| 2014 Q3 | 317.4 Million USD | -7.93% |
| 2014 Q2 | 344.72 Million USD | -0.9% |
| 2014 Q4 | 340.67 Million USD | 7.33% |
| 2014 Q1 | 347.86 Million USD | -0.69% |
| 2014 FY | 340.67 Million USD | -2.74% |
| 2013 Q2 | 277.73 Million USD | 1093.57% |
| 2013 FY | 350.28 Million USD | 491.9% |
| 2013 Q3 | 365 Million USD | 31.42% |
| 2013 Q4 | 350.28 Million USD | -4.03% |
| 2013 Q1 | 23.26 Million USD | -60.68% |
| 2012 FY | 59.17 Million USD | 248.44% |
| 2012 Q4 | 59.17 Million USD | -10.62% |
| 2012 Q3 | 66.21 Million USD | -12.75% |
| 2012 Q2 | 75.88 Million USD | 40.84% |
| 2012 Q1 | 53.88 Million USD | 217.26% |
| 2011 Q3 | 17.71 Million USD | 339.25% |
| 2011 FY | 16.98 Million USD | 441.66% |
| 2011 Q1 | -16.07 Million USD | -223.27% |
| 2011 Q2 | -7.4 Million USD | 53.93% |
| 2011 Q4 | 16.98 Million USD | -4.11% |
| 2010 Q2 | -13.75 Million USD | -140.55% |
| 2010 FY | -4.97 Million USD | -108.91% |
| 2010 Q4 | -4.97 Million USD | -111.15% |
| 2010 Q3 | 44.58 Million USD | 424.04% |
| 2010 Q1 | 33.92 Million USD | -39.22% |
| 2009 Q3 | 104.25 Million USD | 15.09% |
| 2009 Q1 | 129.22 Million USD | 0.87% |
| 2009 FY | 55.82 Million USD | -56.43% |
| 2009 Q4 | 55.82 Million USD | -46.46% |
| 2009 Q2 | 90.58 Million USD | -29.9% |
| 2008 FY | 128.11 Million USD | 159.96% |
| 2008 Q1 | 52.61 Million USD | 6.76% |
| 2008 Q2 | 64.02 Million USD | 21.7% |
| 2008 Q3 | 77.53 Million USD | 21.1% |
| 2008 Q4 | 128.11 Million USD | 65.23% |
| 2007 Q1 | 110.12 Million USD | 153.15% |
| 2007 FY | 49.28 Million USD | 13.28% |
| 2007 Q4 | 49.28 Million USD | -43.51% |
| 2007 Q3 | 87.23 Million USD | -15.74% |
| 2007 Q2 | 103.53 Million USD | -5.99% |
| 2006 Q1 | 91.43 Million USD | 10.18% |
| 2006 Q4 | 43.5 Million USD | -30.79% |
| 2006 FY | 43.5 Million USD | -47.58% |
| 2006 Q3 | 62.85 Million USD | 0.82% |
| 2006 Q2 | 62.33 Million USD | -31.82% |
| 2005 Q3 | 43.4 Million USD | -43.02% |
| 2005 FY | 82.98 Million USD | 153.53% |
| 2005 Q1 | 26.92 Million USD | -17.73% |
| 2005 Q2 | 76.17 Million USD | 182.87% |
| 2005 Q4 | 82.98 Million USD | 91.19% |
| 2004 Q3 | 74.75 Million USD | -18.39% |
| 2004 FY | 32.73 Million USD | -8.37% |
| 2004 Q1 | 98.33 Million USD | 175.28% |
| 2004 Q2 | 91.6 Million USD | -6.85% |
| 2004 Q4 | 32.73 Million USD | -56.22% |
| 2003 Q2 | 86.02 Million USD | -10.72% |
| 2003 Q4 | 35.72 Million USD | -53.55% |
| 2003 Q1 | 96.34 Million USD | -7.77% |
| 2003 Q3 | 76.9 Million USD | -10.6% |
| 2003 FY | 35.72 Million USD | -65.81% |
| 2002 FY | 104.46 Million USD | -42.72% |
| 2002 Q4 | 104.46 Million USD | -19.85% |
| 2002 Q2 | 156.61 Million USD | -4.66% |
| 2002 Q3 | 130.34 Million USD | -16.78% |
| 2002 Q1 | 164.26 Million USD | -9.93% |
| 2001 Q3 | 199.4 Million USD | -12.29% |
| 2001 FY | 182.37 Million USD | -22.41% |
| 2001 Q4 | 182.37 Million USD | -8.54% |
| 2001 Q1 | 231.66 Million USD | -1.44% |
| 2001 Q2 | 227.35 Million USD | -1.86% |
| 2000 Q1 | 241.1 Million USD | 20.55% |
| 2000 Q4 | 235.04 Million USD | -1.7% |
| 2000 Q2 | 236 Million USD | -2.12% |
| 2000 FY | 235.04 Million USD | 17.52% |
| 2000 Q3 | 239.1 Million USD | 1.31% |
| 1999 Q2 | 179.4 Million USD | 34.66% |
| 1999 FY | 200 Million USD | 45.03% |
| 1999 Q1 | 133.22 Million USD | -3.39% |
| 1999 Q4 | 200 Million USD | 0.55% |
| 1999 Q3 | 198.9 Million USD | 10.87% |
| 1998 Q4 | 137.9 Million USD | -0.57% |
| 1998 Q1 | 11.42 Million USD | -25.33% |
| 1998 Q2 | 123.71 Million USD | 982.84% |
| 1998 Q3 | 138.7 Million USD | 12.12% |
| 1998 FY | 137.9 Million USD | 801.35% |
| 1997 Q1 | -42.5 Million USD | -21150.0% |
| 1997 Q2 | -55.7 Million USD | -31.06% |
| 1997 Q3 | 9.7 Million USD | 117.41% |
| 1997 FY | 15.3 Million USD | 7750.0% |
| 1997 Q4 | 15.3 Million USD | 57.73% |
| 1996 FY | -200 Thousand USD | 87.5% |
| 1996 Q1 | -1.6 Million USD | 0.0% |
| 1996 Q2 | -2 Million USD | -25.0% |
| 1996 Q3 | -900 Thousand USD | 55.0% |
| 1996 Q4 | -200 Thousand USD | 77.78% |
| 1995 Q2 | 100 Thousand USD | 103.7% |
| 1995 Q3 | -1.7 Million USD | -1800.0% |
| 1995 Q4 | -1.6 Million USD | 5.88% |
| 1995 Q1 | -2.7 Million USD | 0.0% |
| 1995 FY | -1.6 Million USD | 40.74% |
| 1994 Q4 | -2.7 Million USD | 86.57% |
| 1994 Q3 | -20.1 Million USD | 0.0% |
| 1994 FY | -2.7 Million USD | 86.43% |
| 1994 Q1 | -20.7 Million USD | -4.02% |
| 1994 Q2 | -20.1 Million USD | 2.9% |
| 1993 Q2 | -11.7 Million USD | 13.97% |
| 1993 FY | -19.9 Million USD | -1890.0% |
| 1993 Q1 | -13.6 Million USD | -1260.0% |
| 1993 Q4 | -19.9 Million USD | -64.46% |
| 1993 Q3 | -12.1 Million USD | -3.42% |
| 1992 Q4 | -1 Million USD | 0.0% |
| 1992 FY | -1 Million USD | -350.0% |
| 1991 Q4 | 400 Thousand USD | 0.0% |
| 1991 FY | 400 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 64.619% |
| Allurion Technologies Inc. | 3.82 Million USD | -83045.209% |
| Artivion, Inc. | 300.4 Million USD | -957.302% |
| Avanos Medical, Inc. | 121.4 Million USD | -2516.266% |
| Butterfly Network, Inc. | -109.6 Million USD | 2997.706% |
| Butterfly Network, Inc. | -109.6 Million USD | 2997.706% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | -217.003% |
| Boston Scientific Corporation | 8.62 Billion USD | 63.184% |
| CONMED Corporation | 966.95 Million USD | -228.468% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 807.225% |
| Paragon 28, Inc. | 36.39 Million USD | -8627.837% |
| Glaukos Corporation | 290.27 Million USD | -994.201% |
| Globus Medical, Inc. | 53.11 Million USD | -5880.093% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 2076.556% |
| Integer Holdings Corporation | 1.01 Billion USD | -212.219% |
| Medtronic plc | 24.76 Billion USD | 87.174% |
| Myomo, Inc. | -6.27 Million USD | 50756.228% |
| Nevro Corp. | 117.61 Million USD | -2600.576% |
| Owlet, Inc. | -1.34 Million USD | 236949.319% |
| Penumbra, Inc. | 66.85 Million USD | -4650.657% |
| Vicarious Surgical Inc. | -37.99 Million USD | 8460.482% |
| Smith & Nephew plc | 2.78 Billion USD | -14.168% |
| Sonendo, Inc. | 26.34 Million USD | -11957.349% |
| Stryker Corporation | 10.02 Billion USD | 68.315% |
| Vapotherm, Inc. | 102.66 Million USD | -2993.64% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 43.074% |